Francesca Lunardi

Time, tissue, and team: Reframing transbronchial biopsy in lung transplantation as an integrated diagnostic system.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: July 07, 2026

Toward integrated molecular monitoring of the lung allograft: From tissue biology to clinical translation.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: June 10, 2026

Mapping the mTOR pathway in lung transplantation: Is it time for a biomarker-driven precision therapy?

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: May 21, 2026

A challenging diagnostic journey of antibody-mediated rejection after lung transplantation in a child: a case report.

Journal: Frontiers in medicine

Published: May 18, 2026

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 05, 2026

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

Reframing tumor bed evaluation in non-small cell lung cancer: histopathological challenges and future directions in the era of neoadjuvant immunotherapy.

Journal: Frontiers in oncology

Published: October 01, 2025

Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors.

Journal: Histopathology

Published: May 05, 2025

Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience.

Journal: Frontiers in immunology

Published: April 28, 2025

Time, tissue, and team: Reframing transbronchial biopsy in lung transplantation as an integrated diagnostic system.

Time, tissue, and team: Reframing transbronchial biopsy in lung transplantation as an integrated diagnostic system.

Toward integrated molecular monitoring of the lung allograft: From tissue biology to clinical translation.

Toward integrated molecular monitoring of the lung allograft: From tissue biology to clinical translation.

Mapping the mTOR pathway in lung transplantation: Is it time for a biomarker-driven precision therapy?

Mapping the mTOR pathway in lung transplantation: Is it time for a biomarker-driven precision therapy?

A challenging diagnostic journey of antibody-mediated rejection after lung transplantation in a child: a case report.

A challenging diagnostic journey of antibody-mediated rejection after lung transplantation in a child: a case report.

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey.

Pathologists' experience and routine practice in high-volume lung transplant centers: An international survey.

Lymphangitic breast cancer in explanted lungs with interstitial lung disease: an unexpected finding.

Lymphangitic breast cancer in explanted lungs with interstitial lung disease: an unexpected finding.

Reframing tumor bed evaluation in non-small cell lung cancer: histopathological challenges and future directions in the era of neoadjuvant immunotherapy.

Reframing tumor bed evaluation in non-small cell lung cancer: histopathological challenges and future directions in the era of neoadjuvant immunotherapy.

Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors.

Pathologic assessment of resected stage III non-small cell lung cancer after neoadjuvant chemotherapy: identification of additional prognostic factors.

Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience.

Detection of lung allograft injury through a comprehensive multidisciplinary analysis of donor-derived cell-free DNA in plasma and bronchoalveolar lavage: a real-world single center experience.